Sleep apnea determines soluble TNF-α receptor 2 response to massive weight loss

Maria Pallayova, Kimberley E. Steele, Thomas H. Magnuson, Michael A. Schweitzer, Philip L. Smith, Susheel P. Patil, Shannon Bevans-Fonti, Vsevolod Y. Polotsky, Alan R. Schwartz

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: The effects of surgical weight loss (WL) on inflammatory biomarkers associated with sleep apnea remain unknown. We sought to determine if any biomarkers can predict amelioration of sleep apnea achieved by bariatric surgery. We hypothesized that surgical WL would substantially reduce severity of sleep apnea and levels of proinflammatory cytokines. Methods: Twenty-three morbidly obese adults underwent anthropometric measurements, polysomnography, and serum biomarker profiling prior to and 1 year following bariatric surgery. We examined the effect of WL and amelioration of sleep apnea on metabolic and inflammatory markers. Results: Surgical WL resulted in significant decreases in BMI (16.7∈±∈5.97 kg/m 2/median 365 days), apnea-hypopnea index (AHI), CRP, IL-6, sTNFαR1, sTNFαR2, and leptin levels, while ghrelin, adiponectin, and soluble leptin receptor concentrations increased significantly. Utilizing an AHI cutoff of 15 events/h, we found significantly elevated levels of baseline sTNFαR2 and greater post-WL sTNFαR2 decreases in subjects with baseline AHI ≥15 events/h compared to those with AHI <15 events/h despite no significant differences in baseline BMI, age, and ΔBMI. In a multivariable linear regression model adjusting for sex, age, impaired glucose metabolism, ΔBMI, and follow-up period, the post-WL decreases in AHI were an independent predictor of the decreases in sTNFαR2 and altogether accounted for 46% of the variance of ΔsTNFαR2 (P∈=∈0.011) in the entire cohort. Conclusions: Of all the biomarkers, the decrease in sTNFαR2 was independently determined by the amelioration of sleep apnea achieved by bariatric surgery. The results suggest that sTNFαR2 may be a specific sleep apnea biomarker across a wide range of body weight.

Original languageEnglish
Pages (from-to)1413-1423
Number of pages11
JournalObesity Surgery
Volume21
Issue number9
DOIs
Publication statusPublished - Sep 2011
Externally publishedYes

Fingerprint

Tumor Necrosis Factor Receptors
Sleep Apnea Syndromes
Apnea
Weight Loss
Biomarkers
Bariatric Surgery
Linear Models
Leptin Receptors
Ghrelin
Polysomnography
Adiponectin
Leptin
Interleukin-6
Body Weight
Cytokines
Glucose
Serum

Keywords

  • Bariatric surgery
  • Obesity
  • Sleep apnea
  • Soluble tumor necrosis factor-alpha receptor 2
  • Weight loss

ASJC Scopus subject areas

  • Surgery
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Pallayova, M., Steele, K. E., Magnuson, T. H., Schweitzer, M. A., Smith, P. L., Patil, S. P., ... Schwartz, A. R. (2011). Sleep apnea determines soluble TNF-α receptor 2 response to massive weight loss. Obesity Surgery, 21(9), 1413-1423. https://doi.org/10.1007/s11695-011-0359-4

Sleep apnea determines soluble TNF-α receptor 2 response to massive weight loss. / Pallayova, Maria; Steele, Kimberley E.; Magnuson, Thomas H.; Schweitzer, Michael A.; Smith, Philip L.; Patil, Susheel P.; Bevans-Fonti, Shannon; Polotsky, Vsevolod Y.; Schwartz, Alan R.

In: Obesity Surgery, Vol. 21, No. 9, 09.2011, p. 1413-1423.

Research output: Contribution to journalArticle

Pallayova, M, Steele, KE, Magnuson, TH, Schweitzer, MA, Smith, PL, Patil, SP, Bevans-Fonti, S, Polotsky, VY & Schwartz, AR 2011, 'Sleep apnea determines soluble TNF-α receptor 2 response to massive weight loss', Obesity Surgery, vol. 21, no. 9, pp. 1413-1423. https://doi.org/10.1007/s11695-011-0359-4
Pallayova, Maria ; Steele, Kimberley E. ; Magnuson, Thomas H. ; Schweitzer, Michael A. ; Smith, Philip L. ; Patil, Susheel P. ; Bevans-Fonti, Shannon ; Polotsky, Vsevolod Y. ; Schwartz, Alan R. / Sleep apnea determines soluble TNF-α receptor 2 response to massive weight loss. In: Obesity Surgery. 2011 ; Vol. 21, No. 9. pp. 1413-1423.
@article{0c7cadfa0e974cea870e5d863123cef7,
title = "Sleep apnea determines soluble TNF-α receptor 2 response to massive weight loss",
abstract = "Background: The effects of surgical weight loss (WL) on inflammatory biomarkers associated with sleep apnea remain unknown. We sought to determine if any biomarkers can predict amelioration of sleep apnea achieved by bariatric surgery. We hypothesized that surgical WL would substantially reduce severity of sleep apnea and levels of proinflammatory cytokines. Methods: Twenty-three morbidly obese adults underwent anthropometric measurements, polysomnography, and serum biomarker profiling prior to and 1 year following bariatric surgery. We examined the effect of WL and amelioration of sleep apnea on metabolic and inflammatory markers. Results: Surgical WL resulted in significant decreases in BMI (16.7∈±∈5.97 kg/m 2/median 365 days), apnea-hypopnea index (AHI), CRP, IL-6, sTNFαR1, sTNFαR2, and leptin levels, while ghrelin, adiponectin, and soluble leptin receptor concentrations increased significantly. Utilizing an AHI cutoff of 15 events/h, we found significantly elevated levels of baseline sTNFαR2 and greater post-WL sTNFαR2 decreases in subjects with baseline AHI ≥15 events/h compared to those with AHI <15 events/h despite no significant differences in baseline BMI, age, and ΔBMI. In a multivariable linear regression model adjusting for sex, age, impaired glucose metabolism, ΔBMI, and follow-up period, the post-WL decreases in AHI were an independent predictor of the decreases in sTNFαR2 and altogether accounted for 46{\%} of the variance of ΔsTNFαR2 (P∈=∈0.011) in the entire cohort. Conclusions: Of all the biomarkers, the decrease in sTNFαR2 was independently determined by the amelioration of sleep apnea achieved by bariatric surgery. The results suggest that sTNFαR2 may be a specific sleep apnea biomarker across a wide range of body weight.",
keywords = "Bariatric surgery, Obesity, Sleep apnea, Soluble tumor necrosis factor-alpha receptor 2, Weight loss",
author = "Maria Pallayova and Steele, {Kimberley E.} and Magnuson, {Thomas H.} and Schweitzer, {Michael A.} and Smith, {Philip L.} and Patil, {Susheel P.} and Shannon Bevans-Fonti and Polotsky, {Vsevolod Y.} and Schwartz, {Alan R.}",
year = "2011",
month = "9",
doi = "10.1007/s11695-011-0359-4",
language = "English",
volume = "21",
pages = "1413--1423",
journal = "Obesity Surgery",
issn = "0960-8923",
publisher = "Springer New York",
number = "9",

}

TY - JOUR

T1 - Sleep apnea determines soluble TNF-α receptor 2 response to massive weight loss

AU - Pallayova, Maria

AU - Steele, Kimberley E.

AU - Magnuson, Thomas H.

AU - Schweitzer, Michael A.

AU - Smith, Philip L.

AU - Patil, Susheel P.

AU - Bevans-Fonti, Shannon

AU - Polotsky, Vsevolod Y.

AU - Schwartz, Alan R.

PY - 2011/9

Y1 - 2011/9

N2 - Background: The effects of surgical weight loss (WL) on inflammatory biomarkers associated with sleep apnea remain unknown. We sought to determine if any biomarkers can predict amelioration of sleep apnea achieved by bariatric surgery. We hypothesized that surgical WL would substantially reduce severity of sleep apnea and levels of proinflammatory cytokines. Methods: Twenty-three morbidly obese adults underwent anthropometric measurements, polysomnography, and serum biomarker profiling prior to and 1 year following bariatric surgery. We examined the effect of WL and amelioration of sleep apnea on metabolic and inflammatory markers. Results: Surgical WL resulted in significant decreases in BMI (16.7∈±∈5.97 kg/m 2/median 365 days), apnea-hypopnea index (AHI), CRP, IL-6, sTNFαR1, sTNFαR2, and leptin levels, while ghrelin, adiponectin, and soluble leptin receptor concentrations increased significantly. Utilizing an AHI cutoff of 15 events/h, we found significantly elevated levels of baseline sTNFαR2 and greater post-WL sTNFαR2 decreases in subjects with baseline AHI ≥15 events/h compared to those with AHI <15 events/h despite no significant differences in baseline BMI, age, and ΔBMI. In a multivariable linear regression model adjusting for sex, age, impaired glucose metabolism, ΔBMI, and follow-up period, the post-WL decreases in AHI were an independent predictor of the decreases in sTNFαR2 and altogether accounted for 46% of the variance of ΔsTNFαR2 (P∈=∈0.011) in the entire cohort. Conclusions: Of all the biomarkers, the decrease in sTNFαR2 was independently determined by the amelioration of sleep apnea achieved by bariatric surgery. The results suggest that sTNFαR2 may be a specific sleep apnea biomarker across a wide range of body weight.

AB - Background: The effects of surgical weight loss (WL) on inflammatory biomarkers associated with sleep apnea remain unknown. We sought to determine if any biomarkers can predict amelioration of sleep apnea achieved by bariatric surgery. We hypothesized that surgical WL would substantially reduce severity of sleep apnea and levels of proinflammatory cytokines. Methods: Twenty-three morbidly obese adults underwent anthropometric measurements, polysomnography, and serum biomarker profiling prior to and 1 year following bariatric surgery. We examined the effect of WL and amelioration of sleep apnea on metabolic and inflammatory markers. Results: Surgical WL resulted in significant decreases in BMI (16.7∈±∈5.97 kg/m 2/median 365 days), apnea-hypopnea index (AHI), CRP, IL-6, sTNFαR1, sTNFαR2, and leptin levels, while ghrelin, adiponectin, and soluble leptin receptor concentrations increased significantly. Utilizing an AHI cutoff of 15 events/h, we found significantly elevated levels of baseline sTNFαR2 and greater post-WL sTNFαR2 decreases in subjects with baseline AHI ≥15 events/h compared to those with AHI <15 events/h despite no significant differences in baseline BMI, age, and ΔBMI. In a multivariable linear regression model adjusting for sex, age, impaired glucose metabolism, ΔBMI, and follow-up period, the post-WL decreases in AHI were an independent predictor of the decreases in sTNFαR2 and altogether accounted for 46% of the variance of ΔsTNFαR2 (P∈=∈0.011) in the entire cohort. Conclusions: Of all the biomarkers, the decrease in sTNFαR2 was independently determined by the amelioration of sleep apnea achieved by bariatric surgery. The results suggest that sTNFαR2 may be a specific sleep apnea biomarker across a wide range of body weight.

KW - Bariatric surgery

KW - Obesity

KW - Sleep apnea

KW - Soluble tumor necrosis factor-alpha receptor 2

KW - Weight loss

UR - http://www.scopus.com/inward/record.url?scp=80052387722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052387722&partnerID=8YFLogxK

U2 - 10.1007/s11695-011-0359-4

DO - 10.1007/s11695-011-0359-4

M3 - Article

VL - 21

SP - 1413

EP - 1423

JO - Obesity Surgery

JF - Obesity Surgery

SN - 0960-8923

IS - 9

ER -